BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28602703)

  • 1. Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong.
    Man MY; Shum HP; Chan YH; Chan KC; Yan WW; Lee RA; Lau SKP
    J Hosp Infect; 2017 Sep; 97(1):35-41. PubMed ID: 28602703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong.
    Pau CK; Ma FF; Ip M; You JH
    Infect Dis (Lond); 2015 May; 47(5):283-8. PubMed ID: 25697339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
    Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and molecular epidemiology of plasmid-mediated DHA-type AmpC β-lactamase-producing Klebsiella pneumoniae blood culture isolates, Hong Kong.
    Luk S; Wong WK; Ho AY; Yu KC; To WK; Ng TK
    J Glob Antimicrob Resist; 2016 Dec; 7():37-42. PubMed ID: 27568104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
    Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
    Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
    Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
    Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
    Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of appropriate empirical antibiotics on clinical outcomes in
    Man MY; Shum HP; Li KC; Yan WW
    Hong Kong Med J; 2021 Aug; 27(4):247-257. PubMed ID: 34393109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.
    Papadimitriou-Olivgeris M; Fligou F; Bartzavali C; Zotou A; Spyropoulou A; Koutsileou K; Vamvakopoulou S; Sioulas N; Karamouzos V; Anastassiou ED; Spiliopoulou I; Christofidou M; Marangos M
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1125-1131. PubMed ID: 28102514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
    Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
    BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
    Yang CC; Wu CH; Lee CT; Liu HT; Chen JB; Chiu CH; Chen CH; Chuang FR
    Int J Infect Dis; 2014 Nov; 28():3-7. PubMed ID: 25200093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P; Giannella M; Lewis R; Trecarichi EM; Petrosillo N; Tumbarello M
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Kang CI; Kim SH; Kim DM; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Infect Control Hosp Epidemiol; 2004 Oct; 25(10):860-7. PubMed ID: 15518030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of community-onset extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia in South Korea using national health insurance claims data.
    Lee Y; Kim YA; Kim D; Shin JH; Uh Y; Shin KS; Shin JH; Jeong SH; Park YS
    Int J Antimicrob Agents; 2019 Dec; 54(6):723-727. PubMed ID: 31520781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.